Australia's Genetic Signatures extends gain on deal with Danish hospital
** Shares of molecular diagnostics firm Genetic Signatures GSS.AX rise 7.1% to A$0.15, their highest level since Feb 6 ** Stock extends previous session's nearly 73% surge after signing deal to supply equipment, reagents and consumables for gastrointestinal screening to Hvidovre Hospital in Denmark ** About 6.3 mln traded so far, 13.3x the 30-day average ** Stock down 40% YTD, including moves in current session (Reporting by Jasmeen Ara Shaikh in Bengaluru) ((Jasmeenaraislam.Shaikh@thomsonreuters.com;))
Recent news on Genetic Signatures
See all newsBrief: Genetic Signatures Says Microba Shareholders To Hold 60% Of GSS On Merger
Australia's Genetic Signatures urges largest stakeholder to clarify merger intentions; shares rise
Brief: Genetic Signatures Receives Request From BCAL Diagnostics To Call General Meeting Of Shareholders
Brief: Genetic Signatures Requested BCAL Diagnostics To Clarify Details Of Shareholdings, Associates In Co
Brief: Genetic Signatures Announces Board Changes